跳至主要内容
临床试验/ACTRN12619001728123
ACTRN12619001728123招募中1 期

Pharmacologically Targeting Sleep Spindles to Improve Cognition in Ageing

Woolcock Institute of Medical Research0 个研究点目标入组 24 人开始时间: 2019年12月9日最近更新:

试验速览

阶段
1 期
状态
招募中
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
50 Years 至 75 Years(—)
性别
All

入选标准

  • 1. Males and Females;
  • 2. Age 50-75;
  • 3. Ability to perform neurobehavioural tests;
  • 4. Able to give informed consent;
  • 5. Fluent in English;
  • 6. Cognitively intact (may have subjective memory complaint)

排除标准

  • 1. Mild cognitive impairment, suspected or confirmed dementia or Mini Mental State Examination <24 ;
  • 2. History of cerebrovascular events (e.g. stroke, TIA) associated with persisting cognitive changes
  • 3. Neurological disorders (e.g. Parkinson’s Disease, Epilepsy, Multiple Sclerosis)
  • 4. Myasthenia Gravis
  • 5. Severe hepatic impairment
  • 6. Acute ± severe pulmonary insufficiency
  • 7. Head trauma with associated loss of consciousness > 30 mins
  • 8. Psychiatric disorder including; Bipolar Disorder (I and II) and schizophrenia
  • 9. Current major depressive episode
  • 10. Currently regularly taking regular benzodiazepines, sedatives and hypnotics, and other sleep-affecting medications or any centrally active medications including anti-depressants /polypharmacy.
  • 11. Current substance abuse or dependence (alcohol and/or other illicit substances)
  • 12. Shift-work or trans-meridian travel within 14 days of assessment
  • 13. Obstructive Sleep Apnoea and other sleep disorders;
  • 14. Severe insomnia (insomnia severity index score of 22 or more)
  • 15. Contraindication to MRI scanning.
  • 16. Clinically significant medical condition that may hinder compliance with protocol as determined by the study physician.
  • 17. Pregnancy

研究者

相似试验